Shares of Viking Therapeutics jumped on Thursday after the biotech company a day earlier announced plans to advance its experimental weight loss injection into a late-stage trial earlier than expected ...
Hims & Hers added GLP-1 injections to its weight-loss services Hims & Hers Health Inc (NYSE:HIMS) stock is soaring today, up 29.4% to trade at $18.85 and earlier hitting a three-year high of $20.11.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results